Anavex Life Sciences Corp. reported that a positive dose-response relationship has been observed in its ongoing Phase 2a clinical trial of…
Articles by Ana de Barros, PhD
Tetra Discovery Partners, in collaboration with the NIH Blueprint Neurotherapeutics Network, announced the start of Phase 1 safety trials of…
A recent review discussed how genes implicated in aging and Alzheimer’s disease exhibit epigenetic changes, indicating the same changes might exert a pathogenic…
Drinking alcohol in moderation every day — defined as two-to-three units per day — may be associated with a significantly lower mortality…
High levels of stress can increase the likelihood of elderly people developing mild cognitive impairment — usually a precursor to Alzheimer’s…
Men undergoing androgen deprivation therapy (ADT) for prostate cancer  could be almost twice as likely to be diagnosed with Alzheimer’s disease…
Results from a recent study published in the Scandinavian Journal of Public Health show that mean healthcare costs…
Results from a recent study presented at the 8th International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) revealed…
In a recent study published in the journal JAMDA, a team of researchers from the Institute of…
Findings from a recent study published in the Journal of Alzheimer’s Disease revealed that chemical alterations in brain…